Press Trust of India on MSN
OPPI Annual Summit 2025 Highlights the ‘Power of Partnership’ in Driving India’s Pharma Transformation
OPPI, President & Managing Director, GlaxoSmithKline Pharmaceuticals Limited, said: “The OPPI Annual Summit celebrates the ...
In light of US tariffs, India’s role as a politically neutral, cost-efficient partner is more critical than ever ...
India’s pharmaceutical exports are approaching $30 billion, propelled by a robust CRDMO ecosystem and expanding Global ...
AstraZeneca and Sun Pharma will jointly market SZC, a key hyperkalaemia drug for CKD and heart failure patients, under ...
Just five months after Novo Nordisk launched Wegovy in India, the Danish company has partnered (PDF) with Emcure ...
Under the new arrangement, AstraZeneca and Sun Pharma will each market and distribute SZC under separate brand names.
AstraZeneca Pharma and Sun Pharma have announced an exclusive partnership to promote and distribute SZC for hyperkalaemia treatment under separate brands, aiming to expand patient access across India ...
AstraZeneca Pharma India and Sun Pharma partner to help patients living with hyperkalaemia in India: Our Bureau, Bengaluru Monday, November 17, 2025, 17:20 Hrs [IST] AstraZeneca P ...
Novo Nordisk and Emcure Pharma team up to bring Poviztra, a new weight loss injection, to India. Learn more about this latest ...
Most pharma-grade protein powders sold in India contain low-quality protein, high sugar, and have misleading labels, making ...
Capital Market on MSN
AstraZeneca partners with Sun Pharma for second SZC brand in India
The agreement aims to accelerate access to SZC, an innovative treatment for hyperkalaemia, across the country.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback